Medical & Pharma Expedite Freight Broker
Emergency dedicated truck, hand carry, and white glove for medical and pharma shippers. Cold chain. Chain of custody. US, Canada, Mexico. 24/7.
Surgical case scheduled. Trial site waiting on first dose. Cold chain at the edge of tolerance. Production line in Monterrey paused on a missing API. We’ve answered every one of those calls. Thirty minutes from now, a dedicated vehicle is moving your freight.
When Medical and Pharma Freight Can’t Wait
Medical and pharmaceutical freight is not regular freight. A two-degree temperature excursion can destroy a $200,000 biologic. A broken chain-of-custody document can trigger an FDA investigation. A missed clinical trial delivery can set a drug-approval timeline back months. A surgical instrument set that arrives an hour late means an OR sitting empty and a patient sent home.
The stakes are measured in patient outcomes, regulatory consequences, and millions of dollars. AB&M has moved this freight since 1997. Every load gets a dedicated vehicle, a vetted driver with regulated-freight handling experience, real-time GPS tracking, and chain-of-custody documentation from pickup through delivery confirmation. We’ve never posted to a public load board. We’ve never had a cargo theft or fraud incident. The discipline that gets us called when the freight can’t wait is the same discipline that gets us called the next time.
Cold Chain Integrity Across Every Temperature Class
AB&M maintains cold-chain integrity across the full pharmaceutical temperature range — controlled room temperature (15–25°C), refrigerated (2–8°C), frozen (-20°C and below), and ultra-low temperature (-70°C and below). Temperature monitoring is continuous and documented. Where validated thermal packaging is required, we coordinate with your packaging provider or supply qualified containers. Every delivery includes temperature-log documentation suitable for FDA audit trails.
Ultra-Low Temperature (-70°C) for Cell & Gene Therapy and mRNA
Annual mRNA boosters and the wave of cell-and-gene therapies entering commercial production turned ULT (-70°C and below) from a pandemic emergency into a standing requirement. AB&M coordinates ULT-rated dry shippers, validated thermal packaging, and continuous temperature monitoring for cell therapy, gene therapy, and ultra-cold biologic shipments. We don’t own the freezer fleet — we coordinate vetted, qualified ULT carriers and packaging partners and we manage the chain of custody, monitoring, and exception response end to end. ULT is a specialist lane and benefits from advance dispatch coordination.
What We Transport
Prescription pharmaceuticals, biologics, vaccines, clinical trial materials and Investigational Medicinal Products (IMP), controlled substances with DEA documentation, compounding pharmacy supplies, and diagnostic reagents. We also handle pharmaceutical equipment — lab instruments, compounding equipment, and clean-room components requiring vibration-free, climate-controlled transport.
We move medical device freight as well — surgical instruments, implants, imaging components, and Class I through Class III diagnostic equipment requiring documented chain-of-custody and white-glove handling. Direct-to-patient (DTP) deliveries for decentralized clinical trials, including cold-chain residential delivery on scheduled windows. For medical device OEMs, we coordinate ISO 13485-aware carrier handling on request.
Chain of Custody and Compliance Documentation
Every medical and pharmaceutical shipment includes chain-of-custody documentation from the moment our driver takes possession to the moment your receiving team signs off. We provide proof of delivery with timestamps, temperature logs, and photo documentation when required. For controlled substances, we coordinate DEA-compliant transport documentation with your compliance team. For shipments where unbroken custody is non-negotiable, we route through OBC service rather than ground — our chain-of-custody framework applies the same operational discipline regardless of mode.
Same-Day and Emergency Pharma Delivery
Hospital pharmacies running out of a critical medication. A clinical trial site waiting on investigational product. A compounding pharmacy that needs raw materials before morning. These are the calls we get at 2 AM, and we answer every one. AB&M dispatches pharmaceutical couriers 24/7/365 with dedicated vehicles that maintain cold chain from pickup through delivery — no terminals, no shared loads, no temperature breaks.
Cross-Border Medical & Pharma — US, Canada, Mexico
Pharmaceutical and medical device manufacturing is moving south. API plants, cell-therapy facilities, and Tier-1 device suppliers are scaling fast in Monterrey, Guadalajara, and Saltillo. When a shipment from a Mexico plant has to clear a US border crossing and reach a US distribution point on a deadline — or when an API has to get into a Mexico production line before it goes silent — generalist brokers stall at the border. We don’t.
AB&M coordinates cross-border medical and pharma freight through all eight primary US-Mexico crossings: Laredo, El Paso, Nogales, McAllen, Brownsville, Calexico, Eagle Pass, and Del Rio. One dispatcher manages both sides of the border. Customs-broker partnerships are already in place. C-TPAT-aware carrier selection is standard. Bilingual dispatch is available on request. Documentation is handled before the truck reaches the bridge — not after.
Pharma-specific handling at the crossing matters. COFEPRIS-regulated product moving south, FDA-bound product moving north, controlled-substance documentation, cold-chain validation across customs hold — the same SOP discipline that moves automotive line-down freight through Laredo at 2 AM applies directly to a held pharma shipment in Nuevo Laredo. The crossing doesn’t care what’s in the trailer. The dispatcher does.
Canadian lanes covered with time-definite customs clearance — most commonly Detroit-Windsor, Buffalo-Fort Erie, and Pacific Highway, with provincial coverage from Vancouver to Halifax.
For ongoing US-Mexico ground expedite freight beyond pharma, see US-Mexico Cross-Border Ground Expedite.
OBC & Hand Carry — One Courier, Unbroken Custody
Some pharma shipments cannot ride in a truck — or even on a truck unaccompanied. Cell and gene therapies engineered for a single patient. CAR-T preparations on a 72-hour clock. Short-dated biologics being repositioned before expiration. Investigational product moving to a trial site for a first-dose window that won’t reopen.
For these, AB&M provides on-board courier (OBC) and hand carry service. One trained courier takes possession at origin and personally escorts the shipment to its destination. No transfers, no terminals, no shared cargo. Chain of custody is unbroken because it is literally one set of hands the entire way. TSA-certified couriers available. Domestic and cross-border. Next Flight Out when air is faster than ground.
More on the service: Hand Carry / OBC · Next Flight Out (NFO).
DSCSA-Aware Carrier Vetting
The Drug Supply Chain Security Act went into enforcement for wholesale distributors on August 27, 2025. Large dispensers came into scope November 27, 2025. Small dispensers have until November 27, 2026. Civil penalties for violations run up to $500,000 per occurrence; intentional violations carry criminal exposure.
This isn’t a sticker-on-the-box problem. It’s a chain-of-custody discipline problem. Every carrier in our network is vetted against the documentation, transaction-data, and verification protocols pharma shippers now have to defend in audit. We know which carriers have the systems in place and which ones don’t. We never post pharma freight to public load boards. We’ve operated since 1997 with zero cargo theft and zero fraud incidents — and that record is the foundation our pharma carrier-vetting rests on.
For full carrier-vetting protocol and freight-fraud detail, see Freight Fraud Protection.
Medical & Pharma Expedite Services
Cold Chain Transport
Refrigerated, frozen, and ULT pharmaceutical freight with continuous temperature monitoring, validated containers, and documented chain-of-custody.
FDA-Compliant Documentation
Complete chain-of-custody records, temperature logs, and handling documentation meeting FDA-relevant standards for pharmaceutical transport.
Clinical Trials & IMP
Investigational Medicinal Products (IMP), biological specimens, ancillary trial supplies, and direct-to-patient (DTP) deliveries for decentralized trials. Phase I single-site through global multi-site studies. Documentation CROs and sponsors actually have to defend in audit.
Emergency Pharma Dispatch
When a pharmacy runs out of a critical drug or a clinical site needs emergency supply, AB&M dispatches within the hour.
Who We Serve
- · Pharmaceutical manufacturers (branded, generic, and specialty)
- · Biotech and biologics companies
- · Medical device manufacturers (Class I, II, and III — surgical, implantable, diagnostic)
- · Contract Research Organizations (CROs)
- · Clinical trial sponsors and trial sites
- · Hospital systems and IDNs
- · Specialty and compounding pharmacies
- · Veterinary pharma and medical device companies
- · 3PLs and forwarders moving regulated medical and pharma freight
Server-Grade Discipline, Applied to Medical & Pharma Freight
AB&M built and runs a dedicated server logistics program for one of the world’s largest hyperscale data center buildouts — ESD-compliant handling, full chain of custody, white-glove SOPs, dock-to-rack handoff documented for every move. The same operational discipline that moves a $200,000 server is what moves a $200,000 biologic. Vetted carriers. Documented handoffs. Real dispatchers. Zero shortcuts. Pharma shippers and medical device OEMs hire AB&M for the same reason hyperscale technology companies do — because we treat regulated freight like the high-stakes problem it actually is.
See the program: Data Center Relocation Services.
David King — Director, Client Partnerships
David King is Director of Client Partnerships at AB&M Logistics, where he oversees client relationships, carrier vetting, and operational protocols across the expedite network. Elected to the Airforwarders Association Board of Directors for the 2025-2028 term, David represents carrier and broker concerns at the industry-governance level. He was quoted in the AfA’s October 2025 press release calling on Congress to establish a Federal Cargo Theft and Fraud Task Force — a policy push that reflects more than twenty years spent solving cargo security problems at the operational layer.